coronaviru
diseas
becom
increas
global
health
issu
spread
across
globe
aim
studi
effect
corticosteroid
treatment
adult
inpati
epidem
coronaviru
diseas
covid
emerg
infecti
respiratori
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
perform
retrospect
cohort
studi
effect
corticosteroid
group
patient
aim
provid
scientif
ration
medic
decisionmak
basi
clinician
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
singlecent
retrospect
cohort
studi
includ
individu
diagnos
laboratoryconfirm
consecut
jan
feb
third
peopl
hospit
hubei
provinc
elig
patient
age
year
older
infect
diagnos
realtim
reversetranscriptas
polymerasechainreact
rtpcr
assay
nasal
pharyng
swab
specimen
patient
enrol
studi
diagnos
classifi
accord
new
coronaviru
pneumonia
diagnosi
treatment
plan
trial
version
develop
nation
health
committe
peopl
republ
china
studi
patient
mild
moder
symptom
classifi
noncrit
patient
sever
critic
symptom
classifi
critic
patient
treat
infect
isol
ward
oxygen
satur
vital
sign
close
monitor
chest
ct
scan
laboratori
indic
includ
serial
haematolog
biochem
test
coagul
paramet
inflammationrel
factor
perform
patient
empir
treat
intraven
moxifloxacin
per
day
atyp
typic
pneumonia
arbidol
given
dose
everi
h
togeth
intraven
ribavirin
everi
antivir
therapi
corticosteroid
therapi
commenc
discret
attend
clinician
inform
consent
obtain
patient
next
kin
option
corticosteroid
regimen
puls
intraven
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
methylprednisolon
per
day
day
intraven
methylprednisolon
mgkg
per
day
day
treatment
option
includ
immunoglobulin
interferonalpha
tradit
chines
medicin
combin
primari
endpoint
occurr
advers
outcom
defin
either
mortal
intens
care
unit
icu
admiss
consecut
adult
patient
fulfil
criteria
studi
demograph
characterist
epidemiolog
histori
comorbid
clinic
featur
chest
imag
result
laboratori
indic
corticosteroid
treatment
option
clinic
outcom
obtain
electron
medic
record
data
collect
form
review
independ
two
experienc
physician
categor
variabl
given
frequenc
rate
percentag
continu
variabl
defin
use
mean
median
interquartil
rang
high
lactat
dehydrogenas
level
high
creactiv
protein
level
low
lymphocyt
count
level
low
serum
potassium
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
albumin
use
covari
multipl
logist
regress
adjust
confound
effect
advers
outcom
statist
analys
perform
use
spss
spss
inc
chicago
il
usa
p
consid
statist
signific
tabl
twentynin
patient
reach
advers
outcom
icu
admiss
mortal
patient
advers
outcom
older
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
comorbid
lymphocyt
count
albumin
level
lower
ddimer
creactiv
protein
lactat
dehydrogenas
level
higher
tabl
patient
categor
accord
whether
corticosteroid
treatment
given
compar
term
outcom
well
age
comorbid
establish
advers
prognost
factor
corticosteroid
group
found
comorbid
lower
lymphocyt
count
higher
ldh
age
sex
serum
potassium
albumin
ddimer
creactiv
protein
l
e
vel
similar
group
corticosteroid
group
advers
outcom
vs
statist
signific
differ
observ
tabl
multivari
analysi
perform
adjust
confound
effect
diseas
sever
patient
treat
corticosteroid
found
increas
risk
either
icu
admiss
mortal
although
statist
signific
tabl
acut
respiratori
distress
syndrom
ard
acut
lung
injuri
partli
induc
host
immun
respons
corticosteroid
could
suppress
inflamm
pathogen
clearanc
immun
respons
also
inhibit
time
system
inflamm
associ
advers
outcom
sarscov
infect
inflamm
also
persist
viral
clearanc
theori
corticosteroid
administr
appli
suppress
lung
inflamm
howev
metaanalysi
corticosteroid
use
sar
patient
four
studi
provid
conclus
data
indic
harm
includ
psychosi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
report
knowledg
first
cohort
studi
describ
role
corticosteroid
patient
seri
studi
sever
limit
first
sampl
size
rel
small
result
could
bias
unknown
confound
factor
second
stratifi
outcom
accord
variou
corticosteroid
dosag
method
last
period
conclus
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
studi
need
evalu
clinic
cur
effect
well
appropri
dosag
durat
corticosteroid
treatment
none
dataset
use
andor
analyz
current
studi
avail
correspond
author
reason
request
author
declar
compet
interest
exist
dan
wang
respons
concept
design
studi
dan
wang
qunqun
jiang
juan
wang
respons
acquisit
analysi
data
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
author
read
approv
final
manuscript
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
